Filippo Montemurro: The ASTER 70s Trial Reminds Us that Pragmatism Doesn’t Mean Lack of Depth
Filippo Montemurro, Senior Medical Director at F. Hoffmann La Roche, shared a post on X about a paper Etienne Brain and colleagues authored:
“Just finished giving a “slow reading” to this paper. The ASTER 70s trial reminds us that pragmatism doesn’t mean lack of depth. A must-read. Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years.”
Title: Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial
Authors: Etienne Brain, Olivier Mir, Emmanuelle Bourbouloux, Olivier Rigal, Jean-Marc Ferrero, Sylvie Kirscher, Djelila Allouache, Véronique D’Hondt, Aude-Marie Savoye, Xavier Durando, Francois P Duhoux, Laurence Venat-Bouvet, Emmanuel Blot, Jean-Luc Canon, Florence Rollot-Trad, Hervé Bonnefoi, Telma Roque, Jérôme Lemonnier, Aurélien Latouche, Julie Henriques, Magali Lacroix-Triki, Dewi Vernerey
More posts featuring Filippo Montemurro.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023